亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

腺嘌呤二核苷酸磷酸鈉

 
 
單價 面議對比
詢價 暫無
發貨 江蘇無錫市付款后3天內
過期 長期有效
更新 2024-08-14 08:52
 

無錫景耀生物科技有限公司

企業會員第11年
資料未認證
保證金未繳納
詳細說明

cas號:1184-16-3

分子式:C21H27N7NaO17P3

分子量:765.3868

中文別名:腺嘌呤二核苷酸磷酸鈉,β-煙酰胺腺嘌呤二核苷酸磷酸鈉鹽,β-煙酰胺腺嘌呤二核苷酸磷酸鈉鹽水合物,氧化型[生物學研究用],5,5-二溴-5,6-二氫-6-羥基-2,4(1H,3H)-嘧啶二酮,beta-煙酰胺腺嘌呤二核苷酸磷酸單鈉鹽,β-NADP鈉鹽,三磷酸吡定核苷酸,輔酶Ⅱ(NADP 鈉鹽),氧化型輔酶Ⅱ單鈉鹽

英文別名:Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'→5'-ester with 3-(aminocarbonyl)-1-β-d-ribofuranosylpyridinium hydroxide, inner salt, monosodium salt,beta-Nicotinamide Adenine Dinucleotide Phosphate Sodium Salt Hydrate, oxidized form[for Biochemical Research],β-Nicotinamide adenine dinucleotide phosphate sodium salt hydrate,BETA-NADP-NA,beta-Nicotinamide adenine dinucleotide phosphate (NADP+)mono sodium salt,Beta-Nicotinamide adenine dinucleotide phosphate sodium,BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE SODIUM SALT,B-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE SODIUM SALT

舉報收藏 0評論 0
更多>本企業其它產品
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |